Cortical inhibitory dysfunction in bipolar disorder: A study using transcranial magnetic stimulation

Journal of Clinical Psychopharmacology

Volumn 27, Issue 5, 2007, Pages 493-497

  Levinson, Andrea J ^a   Young, L Trevor ^b   Fitzgerald, Paul B ^c   Daskalakis, Zafiris J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Monash University ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN CORTEX; BRAIN DYSFUNCTION; CLINICAL ARTICLE; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MOTOR CORTEX; NORMAL HUMAN; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION;

ADULT; BIPOLAR DISORDER; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; FUNCTIONAL LATERALITY; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; NEURAL INHIBITION; SEVERITY OF ILLNESS INDEX; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 34548686097     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/jcp.0b013e31814ce524     Document Type: Article

References (31)

1. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 2001;25(1):1-27.
2. Perry W, Minassian A, Feifel D, et al. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry. 2001;50(6):418-424.
3. Olincy A, Martin L. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry. 2005;162(1):43-49.
4. Freedman R, Adams CE, Adler LE, et al. Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. Am J Med Genet. 2000;97(1):58-64.
5. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol (Lond). 1993;471:501-519.
6. Ferbert A, Priori A, Rothwell JC, et al. Interhemispheric inhibition of the human motor cortex. J Physiol. 1992;453:525-546.
7. Daskalakis ZJ, Christensen BK, Fitzgerald PB, et al. The mechanisms of interhemispheric inhibition in the human motor cortex. J Physiol. 2002;543(Pt 1):317-326.
8. Ziemann U, Lonnecker S, Steinhoff BJ, et al. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res. 1996;109(1):127-135.
9. Siebner HR, Dressnandt J, Auer C, et al. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve. 1998;21(9):1209-1212.
10. Daskalakis ZJ, Paradiso GO, Christensen BK, et al. Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol. 2004;557(Pt 2):689-700.
11. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). New York: Biometrics Research; 1995.
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
13. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429- 435.
14. Todtenkopf MS, Vincent SL, Benes FM. A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res. 2005;73(1):79-89.
15. Davies CH, Davies SN, Collingridge GL. Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. J Physiol. 1990;424:513-531.
16. Roick H, von Giesen HJ, Benecke R. On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects. Exp Brain Res. 1993;94(3):489-498.
17. Thompson SM, Gahwiler BH. Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures. J Neurophysiol. 1992;67(6):1698-1701.
18. Werhahn KJ, Kunesch E, Noachtar S, et al. Differential effects on motor cortical inhibition induced by blockade of GABA uptake in humans. J Physiol (Lond). 1999;517(Pt 2):591-597.
19. Wassermann EM, Greenberg BD, Nguyen MB, et al. Motor cortex excitability correlates with an anxiety-related personality trait. Biol Psychiatry. 2001;50(5):377-382.
20. Daskalakis ZJ, Christensen BK, Chen R, et al. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry. 2002;59(4):347-354.
21. MacDonald RL, Barker JL. Enhancement of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons: a common mode of anticonvulsant action. Brain Res. 1979;167(2):323-336.
22. Loscher W, Siemes H. Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children. Lancet. 1984;2(8396):225.
23. Patsalos PN, Lascelles PT. Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat. J Neurochem. 1981;36(2):688-695.
24. Loscher W. In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of rats. Neurosci Lett. 1993;160(2):177-180.
25. Petty F, Rush AJ, Davis JM, et al. Plasma GABA predicts acute response to divalproex in mania. Biol Psychiatry. 1996;39(4):278-284.
26. Olpe HR, Steinmann MW, Pozza MF, et al. Valproate enhances GABAA mediated inhibition of locus coeruleus neurones in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1988;338(6):655-657.
27. Berrettini WH, Nurnberger JI Jr, Hare TA, et al. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol Psychiatry. 1983;18(2):185-194.
28. Motohashi N, Ikawa K, Kariya T. GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders? Eur J Pharmacol. 1989;166(1):95-99.
29. Daskalakis ZJ, Moller B, Christensen BK, et al. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res. 2006;174(3):403-412.
30. Ziemann U. TMS and drugs. Clin Neurophysiol 2004;115(8):1717-1729.
31. Greenberg BD, Ziemann U, Cora-Locatelli G, et al. Altered cortical excitability in obsessive-compulsive disorder. Neurology. 2000;54(1):142-147.